During the past decade, Hopital Rangueil; Service de Nephrologie & D'Immunologie Clinique conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Rangueil; Service de Nephrologie & D'Immunologie Clinique" are "Kidney Transplant Failure" (2 trials), "Kidney Transplantation" (2 trials), "Lupus Nephritis" (2 trials), "Chronic Renal Anemia" (1 trials) and "Glomerular Filtration Rate" (1 trials). Many other conditions were trialed in "Hopital Rangueil; Service de Nephrologie & D'Immunologie Clinique" in a lesser frequency.

Most popular intervention types in "Hopital Rangueil; Service de Nephrologie & D'Immunologie Clinique" are "Drug" (5 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "No intervention" (4 trials), "Methylprednisolone" (3 trials), "Obinutuzumab" (3 trials), "Acetaminophen" (2 trials) and "Diphenhydramine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Rangueil; Service de Nephrologie & D'Immunologie Clinique" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Rangueil; Service de Nephrologie & D'Immunologie Clinique". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hopital Rangueil; Service de Nephrologie & D'Immunologie Clinique, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Rangueil; Service de Nephrologie & D'Immunologie Clinique, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".